Company: XTKG
Filing Date: 2025-06-04
Form Type: 424B5
Source: 0001213900-25-051196
Chunk: 45

Company: X3 Holdings Co., Ltd.
Filing Date: 2025-06-04
Form: 424B5
Chunk 45
---
 and sell up to US$277,700,000, or its equivalent in any other currency, currency units, or composite currency or currencies,
of our Class A ordinary shares, par value US$48, preferred shares, debt securities, warrants to purchase our Class A ordinary shares,
rights and a combination of the foregoing securities, separately or as units, in one or more offerings. We refer to our Class A ordinary
shares, preferred shares, warrants, rights and units collectively as “securities” in this prospectus.

This prospectus provides
a general description of the securities that we may offer. We will provide specific terms of any offering in one or more supplements
to this prospectus. Any prospectus supplement may also add, update, or change information contained in this prospectus. You should carefully
read this prospectus and the applicable prospectus supplement as well as the documents incorporated or deemed to be incorporated by reference
in this prospectus before you purchase any of the securities offered hereby. This prospectus may not be used to offer or sell any securities unless accompanied by the applicable prospectus supplement.

These securities may be offered
and sold in the same offering or in separate offerings; to or through underwriters, dealers, and agents; or directly to purchasers. The
names of any underwriters, dealers, or agents involved in the sale of our securities, their compensation and any options to purchase
additional securities held by them will be described in the applicable prospectus supplement. For a more complete description of the
plan of distribution of these securities, see the section entitled “Plan of Distribution” on page 13.

If any underwriters are involved
in the sale of the securities with respect to which this prospectus is being delivered, the names of such underwriters and any applicable
discounts or commissions and over-allotment options will be set forth in the applicable prospectus supplement. This prospectus also describes
the general manner in which our securities may be offered and sold. If necessary, the specific manner in which our securities may be
offered and sold will be described in a supplement to this prospectus.

Pursuant to General Instruction
I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than
one-third of the aggregate market value of our ordinary shares in any 12-month period so long as the aggregate market value of our outstanding
ordinary shares held by non-affiliates remains below $75,